ITeos Therapeutics (ITOS) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ITOS ITeos Therapeutics

Watchlist

9.550
+0.130+1.38%

Close Oct 16 16:00 ET

9.550
0.0000.00%

Post 16:03 ET

348.78MMarket Cap-3226P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

We're Keeping An Eye On ITeos Therapeutics' (NASDAQ:ITOS) Cash Burn Rate
Simply Wall StSep 18 09:01 ET
ITeos Therapeutics Down Over 29%, on Pace for Largest Percent Decrease Since May 2022 -- Data Talk
Dow JonesSep 16 11:43 ET
ITeos Therapeutics, Upstart Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session
BenzingaSep 16 08:44 ET
Market-Moving News for September 16th
BenzingaSep 16 08:08 ET
ITeos Therapeutics Analyst Ratings
BenzingaSep 16 07:40 ET · Ratings
Piper Sandler Maintains ITeos Therapeutics(ITOS.US) With Buy Rating, Maintains Target Price $36
Moomoo NewsSep 16 07:31 ET · Ratings

Comments

Gobinath

Sep 16 06:13

$ITeos Therapeutics (ITOS.US)$ 🤔

GoldmanStacks

May 13 11:34

ITOS

new strat paying off after days of running simulations, time to scaleup😅

ElusiveTrader

May 10 07:59

$ITeos Therapeutics (ITOS.US)$ Everyday some derpy stock with "therapeutics" in its name goes up 50%. we get it.

Moomoo AI

Mar 6 06:16

Jill DeSimone's appointment to iTeos' Board of Directors is a significant move. Her oncology expertise and business growth record are expected to contribute to iTeos' late-stage biopharmaceutical ambitions.

Press Release: ITeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors

GAME_DAY

Aug 23, 2023 10:39

Current watch ⚡️

$VCI Global (VCIG.US)$ $Bruush Oral Care (BRSH.US)$ $Tivic Health Systems (TIVC.US)$ $Canadian Solar (CSIQ.US)$ $Morgan Stanley (MS.US)$ $Macy's (M.US)$ $AgileThought (AGIL.US)$ $MicroCloud Hologram (HOLO.US)$ $ITeos Therapeutics (ITOS.US)$ $VinFast Auto (VFS.US)$

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

ITOS ITeos Therapeutics

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target